Reed Joshua — SEC insider filings
SEC reporting owner CIK 1746541. 17 insider filings on record with FilingPulse; latest filed 2026-10-09.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2021-03-18 to 2026-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 2 filings — 8,453 shares, $324,530 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 4,900 shares @ $29.68 ($145,441) in Scholar Rock Holding Corp, filed 2025-05-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Scholar Rock Holding Corp (SRRK) | Director | 8 | — | 4 legs · 8,453 sh · $324,530 | 9 |
| Alkermes plc. (ALKS) | SVP, Chief Financial Officer | 3 | — | — | 7 |
| Omega Therapeutics, Inc. (OMGA) | Chief Financial Officer | 4 | — | — | 4 |
| Aldeyra Therapeutics, Inc. (ALDX) | Chief Financial Officer | 2 | — | — | 3 |
Insider filings — Reed Joshua
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-09 | 4 | Alkermes plc. (ALKS) | Option exercise (M): 9,164 · Tax withholding (F): 4,069 @ $40.11 · Option exercise (M): 9,164 (derivative) | EDGAR |
| 2026-07-06 | 4 | Scholar Rock Holding Corp (SRRK) | Sale (S): 2,105 @ $53.50 · Sale (S): 948 @ $54.28 | EDGAR |
| 2026-06-08 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 6,839 @ $0 · Grant/award (A): 4,310 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Alkermes plc. (ALKS) | Grant/award (A): 66,430 (derivative) @ $0 · Grant/award (A): 30,854 (derivative) @ $0 | EDGAR |
| 2025-10-10 | 4 | Alkermes plc. (ALKS) | Grant/award (A): 158,743 (derivative) @ $0 · Grant/award (A): 36,656 (derivative) @ $0 | EDGAR |
| 2025-05-30 | 4 | Scholar Rock Holding Corp (SRRK) | Sale (S): 4,900 @ $29.68 · Sale (S): 500 @ $30.04 | EDGAR |
| 2025-05-23 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 7,632 @ $0 · Grant/award (A): 9,206 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 13,500 @ $0 · Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Omega Therapeutics, Inc. (OMGA) | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2023-06-22 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2023-03-02 | 4 | Omega Therapeutics, Inc. (OMGA) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2022-10-28 | 4 | Omega Therapeutics, Inc. (OMGA) | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2022-06-02 | 4 | Omega Therapeutics, Inc. (OMGA) | Grant/award (A): 320,000 (derivative) @ $0 | EDGAR |
| 2022-05-27 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
| 2022-04-01 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 93,322 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2021-04-14 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 150,185 (derivative) @ $0 | EDGAR |
| 2021-03-18 | 4 | Scholar Rock Holding Corp (SRRK) | Grant/award (A): 15,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1746541 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs